Clinical TrialsSearch results
Number of results: 612
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Intravenous liposomal amphotericin B versus intravenous voriconazole for chronic pulmonary aspergillosis: a multicenter, open-labeled trial in Japan
- Chronic pulmonary aspergillosis
- NEOCI (Nagasaki Evaluation Organization for Clinical Interventions)
- 2009-07-22
Completed
- Safety and Efficacy of investigational drug for Cervical Intraepithelial Neoplasia(CIN)
- CIN (CIN1 or CIN2)
- Hamanishi Junzo
- 2019-03-27
Other
- Randomized Phase III Trial of Paclitaxel plus Carboplatin (TC) Therapy versus Irinotecan plus Cisplatin (CPT-P) Therapy as a First Line Chemotherapy for Clear Cell Carcinoma of the Ovary
- clear cell carcinoma of the ovary
- Japanese Gynecologic Oncology Group
- 2006-10-10
Other
- Single-arm confirmatory study on efficacy of combined treatment of endoscopic mucosal resection and chemoradiotherapy for clinical stage I esophageal carcinoma (JCOG0508)
- clinical stage I (SM1-2) esophageal cancer
- Japan Clinical Oncology Group(JCOG)
- 2006-12-21
Other
- The screening method of reduced-function CYP2C19 polymorphisms in Japanese male
- clopidgrel resistance
- Department of Cardiovascular Medicine, Kyoto University Hospital
- 2009-08-01
Other
- An Open-Label Randomized Phase III Study of Capecitabine(6 months) versus Capecitabine(12 months) as Adjuvant Chemotherapy for Stage III(Dukes'C) Colon Cancer Patients.
- Colon cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2008-09-10
Other
- Biomarker-Cohort Study of Adjuvant Chemotherapy for Stage III Colon Cancer
- Colon cancer
- Tokyo Medical and Dental University
- 2009-05-29
Other
- Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal dysfunction following colon surgery
(a randomized, double-blind, multi-center, placebo-controlled study)
- Colon cancer including RS cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2009-01-01
Other
- A phase II trial of FOLFIRI combined with hyperthermia as second-line therapy of unresectable colon cancer with liver metastases
- Colon cancer patients with liver metastases who had been treated by FOLFOX as first-line therapy
- Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine
- 2009-06-01
Other
- A multicenter phase II study of FOLFIRI as first-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with homozygous for UGT1A1(FLIGHT1)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-01